TIM-3: a Crucial Regulator of NK Cells in Pregnancy
Overview
Authors
Affiliations
The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy.
Sun H, Sun C Front Immunol. 2019; 10:2354.
PMID: 31681269 PMC: 6812684. DOI: 10.3389/fimmu.2019.02354.
Li Z, Wang L, Liu H, Muyayalo K, Huang X, Mor G Front Immunol. 2019; 9:3142.
PMID: 30687334 PMC: 6335255. DOI: 10.3389/fimmu.2018.03142.
Cytokine-Based Generation of CD49aEomes Natural Killer Cell Subsets.
Ni X, Fu B, Zhang J, Sun R, Tian Z, Wei H Front Immunol. 2018; 9:2126.
PMID: 30319610 PMC: 6167425. DOI: 10.3389/fimmu.2018.02126.
Challenges of NK cell-based immunotherapy in the new era.
Fang F, Xiao W, Tian Z Front Med. 2018; 12(4):440-450.
PMID: 30047028 DOI: 10.1007/s11684-018-0653-9.
Wang X, Zhou W, Hou X, Fu Q, Li D Cell Mol Immunol. 2018; 15(12):1038-1046.
PMID: 29588487 PMC: 6269500. DOI: 10.1038/s41423-018-0019-x.